Target intelligence / Profile preview

Natural Killer Group 2 Member D ligands (NKG2DL)

Target
NKG2DL
Molecular classification
MHC class I-like protein, Cell surface ligand
01

Overview

Natural Killer Group 2 Member D (NKG2D) ligands, primarily comprising MHC class I polypeptide-related sequence A (MICA), MICB, and the UL16-binding protein (ULBP) family, are stress-induced proteins that act as critical recognition signals for the innate and adaptive immune systems (Duan et al., 2019, Frontiers in Immunology). These ligands are typically absent from healthy tissues but are highly expressed on the surface of cells undergoing malignant transformation, viral infection, or oxidative stress (Lanier, 2015, Nature Reviews Cancer). Upon binding to the NKG2D receptor on NK cells and cytotoxic T cells, they trigger the release of perforin and granzymes, leading to the lysis of the target cell (Zingoni et al., 2018, Frontiers in Immunology). Related immune-activating systems include the DNAM-1 receptor and its ligands (CD155/CD112) and the NKp30 receptor and its ligand B7-H6, which collectively coordinate innate tumor surveillance. In many cancers, the therapeutic potential of this axis is hampered by 'shedding,' where proteolytic cleavage releases soluble ligands that act as decoys, systemically downregulating NKG2D expression and facilitating immune escape (Ferrari de Andrade et al., 2018, Science). Current drug development efforts focus on monoclonal antibodies that block this shedding, bispecific engagers that redirect immune cells to NKG2DL-positive tumors, and CAR-T cells (such as CYAD-01) engineered with the NKG2D extracellular domain to recognize the broad array of ligands presented by various tumor types (Sallman et al., 2023, Journal of Clinical Oncology).

Other names
MHC class I polypeptide-related sequence AMHC class I polypeptide-related sequence BMICAMICBUL16-binding proteinsULBP1ULBP2ULBP3ULBP4ULBP5ULBP6RAET1B7-H6CD155CD112Stress-induced ligands
02

Mechanism of action

Activation of NKG2D-mediated cytotoxicity and prevention of ligand shedding from the tumor cell surface.

03

Biological functions

Immune responseNK cell activationT cell costimulationCellular stress response
04

Disease associations

CancerViral infectionAutoimmune disease
05

Safety considerations

Cytokine release syndrome (CRS)On-target off-tumor toxicity on stressed healthy tissuesImmune evasion via proteolytic sheddingDecoy receptor interference
06

Interacting drugs

CYAD-01

3 more in the full profile.

07

Biomarkers

Soluble MICA (sMICA)Soluble MICB (sMICB)NKG2D expression on tumor-infiltrating lymphocytesB7-H6 surface expression

Beyond the preview

Go deeper on Natural Killer Group 2 Member D ligands (NKG2DL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Killer Group 2 Member D ligands (NKG2DL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call